beta-lactams has been researched along with dactinomycin in 1 studies
Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (dactinomycin) | Trials (dactinomycin) | Recent Studies (post-2010) (dactinomycin) |
---|---|---|---|---|---|
7,579 | 179 | 3,395 | 19,045 | 355 | 969 |
Protein | Taxonomy | beta-lactams (IC50) | dactinomycin (IC50) |
---|---|---|---|
RAD51 | Homo sapiens (human) | 32.1 | |
Growth factor receptor-bound protein 2 | Homo sapiens (human) | 5 | |
Discoidin domain-containing receptor 2 | Homo sapiens (human) | 9 | |
Growth factor receptor-bound protein 2 | Mus musculus (house mouse) | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atherton, E; Kondo, M; Meienhofer, J; Moore, S; Patel, RP | 1 |
1 other study(ies) available for beta-lactams and dactinomycin
Article | Year |
---|---|
Synthesis and some properties and antitumor effects of the actinomycin lactam analog, (di(1-L-alpha, beta-diaminopropionic))actinomycin D1.
Topics: Animals; Antibiotics, Antineoplastic; beta-Lactams; Circular Dichroism; Dactinomycin; Leukemia L1210; Leukemia, Experimental; Male; Melanoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental | 1976 |